The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment.
Clin Rheumatol
; 27(11): 1467-8, 2008 Nov.
Article
en En
| MEDLINE
| ID: mdl-18704546
ABSTRACT
We describe a 38-year-old patient with relapsing remitting multiple sclerosis who subsequently develops systemic sclerosis following a course of interferon B-1a injections. This rare association between MS and systemic sclerosis is interesting due to the added factor of beta interferon therapy prior to the onset of the systemic sclerosis. It is also important, as more patients are treated with interferon B-1a for multiple sclerosis, this is a potential association.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Interferón beta
/
Esclerosis Múltiple Recurrente-Remitente
/
Esclerodermia Limitada
/
Factores Inmunológicos
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Clin Rheumatol
Año:
2008
Tipo del documento:
Article
País de afiliación:
Australia